Article info
Therapeutics
Randomised controlled trial
The quadrivalent HPV vaccine is effective prophylaxis against HPV-related external genital lesions in young men
- Correspondence to Basil Donovan
Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia;bdonovan{at}kirby.unsw.edu.au
Citation
The quadrivalent HPV vaccine is effective prophylaxis against HPV-related external genital lesions in young men
Publication history
- First published May 10, 2011.
Online issue publication
September 16, 2011
Article Versions
- Previous version (10 May 2011).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions